• English English English en
  • Español Español Spanish es
e-mail: info@neurofixpharma.com
  • THE COMPANY
  • AGREEMENTS
  • SHAREHOLDERS
  • NEWS
  • CONTACT
  • Search
  • Menu Menu
  • LinkedIn
  • Twitter
  • Facebook

Neurofix Pharma will participate in the major biotechnology events.

0 Comments
/
24 de August de 2023
https://neurofixpharma.com/wp-content/uploads/2023/08/12-13.png 1080 1920 Juan Tostado https://neurofixpharma.com/wp-content/uploads/2022/05/neurofix-1-2.svg Juan Tostado2023-08-24 13:33:412023-08-24 17:40:12Neurofix Pharma will participate in the major biotechnology events.

ULTIMAS NOTICIAS NEUROFIX

  • Neurofix Pharma will participate in the major biotechnology events.24 de August de 2023 - 13:33
  • Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca28 de November de 2022 - 08:46
  • Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial11 de November de 2022 - 15:42

Tweets by NeurofixS

NEUROFIX INVERSORES

  • SERVICES
  • AGREEMENTS
  • SHAREHOLDERS
  • HITOS IMPORTANTES

NEUROFIX COMPAÑÍA

  • THE COMPANY
  • Neurofix team
  • CONTACT
  • NEWS
  • LEGAL WARNING

ACTUALIDAD NEUROFIX

  • Neurofix Pharma will participate in the major biotechnology events.24 de August de 2023 - 13:33
  • Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca28 de November de 2022 - 08:46
  • Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial11 de November de 2022 - 15:42

NEUROFIX CONTACT

University of Salamanca Science Park
Santibáñez del Río Street 2, M3 building , PB05, room 1
37185 Villamayor, Salamanca

Chamartín Station, first floor, no number
28036 Madrid (Spain)

© Copyright - Neurofix Pharma -2022 | Diseñado por Idimad 360
  • LinkedIn
  • Twitter
  • Facebook
Scroll to top